KONTROLLIERTE ABGABE VON PROBEN AUF SUBSTRATE

European patent · EP2872869 · In force

Register entry

Publication number
EP2872869
Application number
EP13742342
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 15, 2013
Published
May 20, 2015
Granted
May 27, 2020
Protection ends at the latest
Jul 14, 2033
Next annual fee due
Jul 31, 2027
IPC classes
G01N 1/28 (2006.01)
G01N 35/10 (2006.01)
G01C 3/06 (2006.01)
G06T 7/00 (2017.01)
Priority
US 201261671600 P 13.07.2012
PCT application
PCT/US2013/050519 15.07.2013
PCT publication
WO2014/012100 16.01.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. May 27, 2020

    Granted

    Published in Swissreg on 27.05.2020

Parties

Holder

Roche Diagnostics Hematology, Inc.

9115 Hague Rd., Indianapolis IN 46250, US

Inventor

ZAHNISER, Michael

Jamaica Plain, Massachusetts 02130, US

CONROY, Stephen

Maynard, Massachusetts 01754, US

ZAHNISER, David

Wellesley, Massachusetts 02481, US

ZAHNISER, Russell

Dorchester, Massachusetts 02124, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.